Medicine and Dentistry
Doxorubicin
100%
Coenzyme M
100%
Blood Proteins
100%
Combination Therapy
23%
Anthracycline
23%
Sequela
15%
Toxicity
15%
Child
15%
Brain
7%
Cyclophosphamide Plus Doxorubicin Plus Prednisolone Plus Rituximab Plus Vincristine
7%
Chemotherapy Regimens
7%
Stress
7%
Patient
7%
Antioxidant
7%
Non-Hodgkin Lymphoma
7%
Breast Cancer
7%
In Vitro
7%
Ifosfamide
7%
Program Director
7%
Heart Injury
7%
Drug Interaction
7%
Cystitis
7%
Heart
7%
Combination Chemotherapy
7%
Chemotherapeutic Agent
7%
Cardiomyopathy
7%
Drug
7%
Cancer Therapy
7%
Antibody
7%
Macrophage Cell Line
7%
Metronidazole
7%
Alkylating Antineoplastic Agent
7%
Cardiotoxicity
7%
Cells
7%
Animal Study
7%
Cancer Chemotherapy
7%
Pharmacology, Toxicology and Pharmaceutical Science
Doxorubicin
100%
Coenzyme M
100%
Plasma Protein
100%
Anthracycline
23%
Toxicity
15%
Animal
15%
Chemotherapy
15%
Antioxidant
7%
Breast Cancer
7%
Cardiomyopathy
7%
Cardiotoxicity
7%
Ifosfamide
7%
Drug Interaction
7%
Metronidazole
7%
Cyclophosphamide Plus Doxorubicin Plus Prednisolone Plus Rituximab Plus Vincristine
7%
Nonhodgkin Lymphoma
7%
Cystitis
7%
Drug
7%
Alkylating Agent
7%
Heart Injury
7%
Antibody
7%
Malignant Neoplasm
7%
Cancer Chemotherapy
7%
Biochemistry, Genetics and Molecular Biology
Doxorubicin
100%
Mesna
100%
Plasma Protein
100%
Anthracycline
23%
Tumor Necrosis Factor
23%
Alpha Oxidation
15%
Animal Experiment
7%
In Vitro Study
7%
Stress
7%
Drug Interaction
7%
Antibody
7%
Ifosfamide
7%
Macrophage
7%
Animal Models
7%
Clinical Study
7%
Clinical Trial
7%